Reducing fracture risk in patients with Parkinson's disease
Prevention of Fractures in Patients with Parkinson's Disease
['FUNDING_R01'] · CALIFORNIA PACIFIC MED CTR RES INSTITUTE · NIH-10863965
This study is looking at ways to help people with Parkinson's disease avoid fractures, since they often fall more and are at greater risk; it will test if vitamin D and other treatments can make a difference in keeping them healthy and safe.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | CALIFORNIA PACIFIC MED CTR RES INSTITUTE (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-10863965 on ClinicalTrials.gov |
What this research studies
This research investigates how to prevent fractures in patients with Parkinson's disease, who are at a significantly higher risk of fractures due to frequent falls. The study aims to address barriers that prevent these patients from receiving effective osteoporosis treatments, including lack of evidence for their effectiveness in this population and challenges related to medical visits and medication adherence. By conducting a randomized trial, the research will explore the impact of vitamin D supplementation and other interventions on fracture risk and overall health outcomes for these patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 65 or older with Parkinson's disease who are at high risk for fractures.
Not a fit: Patients with Parkinson's disease who are younger than 65 or those without a significant risk of fractures may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved fracture prevention strategies for patients with Parkinson's disease, enhancing their quality of life and reducing mortality associated with fractures.
How similar studies have performed: Previous research has shown that addressing barriers to osteoporosis treatment can improve outcomes, but this specific approach in Parkinson's disease is relatively novel.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- CALIFORNIA PACIFIC MED CTR RES INSTITUTE — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CUMMINGS, STEVEN RON — CALIFORNIA PACIFIC MED CTR RES INSTITUTE
- Study coordinator: CUMMINGS, STEVEN RON
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.